Shareholder Notices
Shareholder notices back to 2018 are available below.
-
Credit of Final Cash Dividend 2022
CREDIT OF FINAL CASH DIVIDEND (D-99) FOR THE YEAR ENDED DECEMBER 31, 2021
Read more -
2022 Notice of Annual General Meeting
2022 Notice of annual general meeting
Read more -
Corporate Briefing Session 2021
Corporate Briefing Session. GlaxoSmithKline Pakistan Limited
Read more -
Newspaper notice to Shareholders for Conversion of Physical Shares to Book Entry Form
Published in Business Recorder, Jang, Nawa e Waqt and Observer
Read more -
Credit of Final Cash Dividend 2021
CREDIT OF FINAL CASH DIVIDEND (D-98) FOR THE YEAR ENDED DECEMBER 31, 2020
Read more -
2021 Notice of Annual General Meeting
2021 Notice of Annual General Meeting
Read more -
Credit of Final Cash Dividend
CREDIT OF FINAL CASH DIVIDEND (D-97) FOR THE YEAR ENDED DECEMBER 31, 2019
Read more -
2020 Election of Directors
Election of directors at the Annual General Meeting of the company schedule to held on Thursday 21 May
Read more -
2020 Notice of Annual General Meeting
2020 Notice of annual general meeting
Read more -
Corporate Briefing Session
Corporate Briefing Session GlaxoSmithKline Pakistan Limited
Read more -
Credit of Final Cash Dividend 2019
CREDIT OF FINAL CASH DIVIDEND (D-96) FOR THE YEAR ENDED DECEMBER 31, 2018
Read more -
2019 Notice of Annual General Meeting
2020 Notice of annual general meeting
Read more -
Credit of Final Cash Dividend 2018
Credit of Final Cash Dividend
Read more -
Notice to Shareholders Under Section 242
Notice to Shareholders Under Section 242 of Companies ACT, 2017 Mandatory Payment of Dividend Through Electronic Mode
Read more -
Final Notice Under section 244(1) (b) of the Companies Act 2017
Final Notice Under section 244(1) (b) of the Companies Act 2017
Read more -
2018 Notice of Annual General Meeting
71st Annual General Meeting of GlaxoSmithKline Pakistan Limited
Read more
Find out more about us
-
Investors
Information for investors including share information, share analysis, shareholder news and annual reports.
-
GSK in Pakistan
GSK is a long-established investor in Pakistan. Our legacy company GlaxoLaboratories Pakistan Ltd.
-
Board of Directors Pakistan
Our Board has established a corporate governance framework with clearly defined responsibilities and accountabilities.
-
Management Committee
The Management Committee comprises of 13 senior members including Directors.
